BTM (BPC / TB500 / MGF) – 18.5mg

BTM is a triple peptide blend combining BPC-157, TB-500, and Mechano Growth Factor (MGF) into a single 18.5mg lyophilized vial, pairing the most extensively co studied tissue repair peptide combination in preclinical literature with MGF’s targeted muscle and connective tissue growth factor activity. iLab Pharma’s lyophilized vial format preserves the structural integrity and potency of all three peptide components across storage conditions until reconstitution, maintaining compound activity across the extended research timelines that tissue repair and regenerative biology protocols typically require.

Each compound contributes a distinct and complementary mechanism to the blend’s overall research profile. BPC-157 promotes angiogenesis through nitric oxide pathway modulation, upregulates growth hormone receptors in injured tissue, and activates the FAK paxillin pathway driving cell migration and wound healing. It helps provide the vascular development and growth factor signaling foundation across multiple tissue types. TB-500 operates through LKKTETQ actin binding domain mediated upregulation of actin polymerization and cell motility pathways. Enhancing cellular migration to injury sites and supporting complementary angiogenic activity through a mechanism distinct from BPC-157’s nitric oxide pathway. MGF (Mechano Growth Factor) is a splice variant of IGF-1 produced locally in muscle and connective tissue in response to mechanical stress and damage; activating satellite cell proliferation through a unique E domain peptide sequence that is not present in systemic IGF-1, stimulating the muscle stem cell response specifically at the site of mechanical injury rather than through the systemic IGF-1 receptor pathway that full length IGF-1 and IGF-DES engage.

MGF’s inclusion in this blend is the defining research differentiator from CSD’s other BPC-157 and TB-500 combination formats. The Wolverine Stack, Wolverine Pen, Glow Pen, KLOW Pen, and KLOW Protocol all combine BPC-157 and TB-500 with additional compounds targeting vascular, extracellular matrix, or anti inflammatory pathways. BTM’s MGF addition introduces a satellite cell activation and local muscle growth factor dimension that none of the other combination formats include: making it the most specifically muscle and connective tissue targeted blend in CSD’s regenerative peptide range, and a uniquely valuable research tool for protocols examining the combined vascular, cellular, and local growth factor response to tissue injury.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity across all three components before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s BTM meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched in muscle repair, connective tissue, and regenerative biology research contexts. Browse CSD’s full peptide range for complete sourcing.